Eli Lilly, Medtronic to collaborate on Parkinson's treatment

Seeking a new way to treat Parkinson's, Eli Lilly and Medtronic have agreed to work together on an approach that involves delivering a potential new medicine to the brain using an implantable drug delivery system. "By collaborating with Medtronic from the earliest phase of research, we are maximizing the potential for this therapy's efficient and effective development," said Michael Hutton, CSO of the neurodegeneration team at Lilly. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.